Influence of captopril on nitroglycerin-mediated vasodilation and development of nitrate tolerance in arterial and venous circulation (Q34732621)

4 August 2017

Influence of captopril on nitroglycerin-mediated vasodilation and development of nitrate tolerance in arterial and venous circulation (English)

1 reference

4 August 2017

Pizzulli L

1

1 reference

4 August 2017

Hagendorff A

2

1 reference

4 August 2017

Zirbes M

3

1 reference

4 August 2017

Fehske W

4

1 reference

4 August 2017

Ewig S

5

1 reference

4 August 2017

Jung W

6

1 reference

4 August 2017

Lüderitz B

7

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

4 August 2017

American Heart Journal

1 reference

4 August 2017

131

1 reference

4 August 2017

2

1 reference

4 August 2017

342-349

1 reference

Tolerance to organic nitrates

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Tolerance to isosorbide dinitrate: rate of development and reversal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Different susceptibility to the development of nitroglycerin tolerance in the arterial and venous circulation in humans. Effects of N-acetylcysteine administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Preventive administration of intravenous N-acetylcysteine and development of tolerance to isosorbide dinitrate in patients with angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Prevention and reversal of tolerance to nitroglycerine with N-acetylcysteine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Prevention and reversal of nitrate tolerance in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Potentiation of isosorbide dinitrate-induced coronary dilatation by captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Captopril potentiates the effects of nitroglycerin in the coronary vascular bed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Prevention of nitrate tolerance with angiotension converting enzyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Altered spectrum of nitroglycerin action in long-term treatment: nitroglycerin-specific venous tolerance with maintenance of arterial vasodepressor potency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Nitrate tolerance in heart failure: differential venous, pulmonary and systemic arterial effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Antianginal, hemodynamic and coronary vascular effects of captopril in stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Altered peripheral vesodilator profile of nitroglycerin during long-term infusion of N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Methionine restores the venodilative response to nitroglycerin after the development of tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Nitrate tolerance: the lack of effect of N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Determinants of in vitro nitroglycerin tolerance induction and reversal: influence of dose regimen, nitrate-free period, and sulfhydryl supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in vivo, but tolerance-independent interactions exist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Angiotensin II. Adrenergic sympathetic constrictor action in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990364-6

10.1016/S0002-8703(96)90364-6

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference